CG Capital Markets said Perrigo (NYSE:PRGO) has no exposure to lawsuits filed against Abbott (ABT) and Reckitt Benckiser (OTCPK:RBGPF) over the safety of their respective baby formulas for ...

In another update, Piper Sandler has downgraded Perrigo’s stock rating from Overweight to Neutral, citing concerns over the infant formula segment and potential pressures on the company’s ...

Perrigo is a focused OTC consumer healthcare ... Despite short-term pressures from a weak cold-and-flu season and infant formula production issues, PRGO is positioned for recovery and growth ...

The infant formula segment showed a 3% increase in net sales year-over-year, although year-to-date net sales decreased by 7.5%. Piper Sandler recently downgraded Perrigo's stock rating from ...

Perrigo Company plc (NYSE: PRGO), a leading global provider of Consumer Self-Care Products, today announced that its Board of Directors has approved a 5% increase in the Company's quarterly ...

To wit, the Perrigo Company plc (NYSE ... and revenue have changed over time in the image below (click on the chart to see the exact values). NYSE:PRGO Earnings and Revenue Growth January 28th ...